A global leader in blood management, blood safety, therapeutic apheresis, cell therapy and cell collections.
Consulting Services to provide overview of healthcare changes in the United States, financial reimbursement impact, and generating financial value within Blood Services and Management marketplace.
Amwell’s telehealth solution spans the care continuum from urgent care to acute care.
A Financial Value Assessment to quantify the financial value of AmWell’s telehealth platform for health systems.
Develops software to drive efficiency in healthcare and improve healthcare outcomes.
Two Financial Value Assessments, one for Payors and one for Providers, focusing on Orion’s financial value of Population Health Management software in both Fee-for-Service and Value-based Care reimbursement environments.
Builds revolutionary new ventures with the world’s most influential corporations.
BCG contracted with FHG to develop a Financial Value Assessment for a BCG Digital Ventures partner company.
The National Lung Cancer Roundtable (NLCRT) is a consortium of public, private, and voluntary organizations that work together to fight lung cancer by engaging in the research and projects that no one organization can take on alone.
Distributed by NLCRT, FHG created a financial forecasting tool to assist in understanding the financial impact of the implementation and expansion of high quality lung cancer screening and pulmonary nodule evaluation programs
Healthcare consulting firm that provides advisory, implementation and optimization services and solutions.
Provided consulting services to evaluate the financial benefit opportunities for health system EHR implementations.